Search - tctmd.com

Displaying 101 - 120 of 606

Sort: Relevancy | Date

Presentation TCT 2017

The Self-expanding Single-operator CENTERA TAVR System

Presenter: Jeffrey J. Popma, John G. Webb, Didier Tchetche

October 31, 2017

Presentation TCT 2017

The Venus A and Venibri TAVR Systems Better for Bicuspids and Dry Leaflet Technology

Presenter: Jeffrey J. Popma, John G. Webb, Horst Sievert

October 31, 2017

Presentation TCT 2017

The Anatomically Correct JenaValve TAVR System Pure AR Treatment

Presenter: Jeffrey J. Popma, John G. Webb, Hendrik Treede

October 31, 2017

Presentation TCT 2017

PORTICO Insights From EU Operators (With Case Examples)

Presenter: Ganesh Manoharan

October 31, 2017

Presentation TCT 2017

PORTICO TAVR Technology Review and Clinical Program Updates

Presenter: Gregory P. Fontana

October 31, 2017

Presentation TCT 2017

ACURATE Neo Insights From EU Operators (With Case Examples)

Presenter: Ulrich Schäfer

October 31, 2017

Presentation TCT 2017

ACURATE Neo TAVR Technology Review and Clinical Program Updates

Presenter: Thomas Walther

October 31, 2017

Presentation TCT 2017

Sex and Racial Disparities in TAVR

Presenter: Alice K. Jacobs, Spencer B. King III, David R. Holmes Jr.

October 31, 2017

Presentation TCT 2017

LOTUS Procedural Pearls (Including How NOT to Need a New Pacemaker)

Presenter: Nicolas M. Van Mieghem

October 31, 2017

Presentation TCT 2017

LOTUS TAVR Technology Review (Including EDGE) and Clinical Program Updates

Presenter: Michael J. Reardon

October 31, 2017

Presentation TCT 2017

FDA Perspectives on TAVR Label Expansion Using Real-World Evidence, Valve Degeneration, and Embolic Protection Devices

Presenter: Martin B. Leon, Changfu Wu, John C Laschinger

October 31, 2017

Presentation TCT 2017

EVOLUT R Procedural Pearls (Including how NOT to Need a New Pacemaker)

Presenter: Hemal Gada

October 31, 2017

Presentation TCT 2017

Valve Degeneration and Leaflet Mobility Considerations: Assessing Clinical Relevance

Presenter: Martin B. Leon, Changfu Wu, Lars Sondergaard

October 31, 2017

Presentation TCT 2017

EVOLUT R TAVR Technology Review (Including EVOLUT 34mm and PRO) and Clinical Program Updates

Presenter: John K. Forrest

October 31, 2017

Presentation TCT 2017

Embolic Protection Devices For TAVR Procedures: Lessons Learned From SENTINEL and Other Experiences

Presenter: Martin B. Leon, Changfu Wu

October 31, 2017

Presentation TCT 2017

SAPIEN 3 Procedural Pearls (Including Optimal Sizing Algorithms)

Presenter: Susheel K. Kodali

October 31, 2017

Presentation TCT 2017

SAPIEN 3 TAVR Technology Review (Including Sapien 3 ULTRA) and Clinical Program Updates

Presenter: John G. Webb

October 31, 2017

News Conference News TCT 2017

Intermediate-Risk TAVR Substantially More Cost-effective Than Surgery

Yael L. Maxwell

October 31, 2017

Presentation TCT 2017

Industry Perspective on Real-World Evidence for TAVR Outcomes Where are the Opportunities?

Presenter: Martin B. Leon, Changfu Wu, Larry L. Wood

October 31, 2017

Presentation TCT 2017

TCT 40: Outcome Of Patients Undergoing Trans-Catheter Implantation of Aortic Valve With Previous Mitral Valve Prosthesis (Optimal Study)

Presenter: Jean-Claude Laborde, Eric Van Belle, Luca Baldetti, MD

October 31, 2017

Advertisement

The Self-expanding Single-operator CENTERA TAVR System

The Venus A and Venibri TAVR Systems Better for Bicuspids and Dry Leaflet Technology

The Anatomically Correct JenaValve TAVR System Pure AR Treatment

PORTICO Insights From EU Operators (With Case Examples)

PORTICO TAVR Technology Review and Clinical Program Updates

ACURATE Neo Insights From EU Operators (With Case Examples)

ACURATE Neo TAVR Technology Review and Clinical Program Updates

Sex and Racial Disparities in TAVR

LOTUS Procedural Pearls (Including How NOT to Need a New Pacemaker)

LOTUS TAVR Technology Review (Including EDGE) and Clinical Program Updates

FDA Perspectives on TAVR Label Expansion Using Real-World Evidence, Valve Degeneration, and Embolic Protection Devices

EVOLUT R Procedural Pearls (Including how NOT to Need a New Pacemaker)

Valve Degeneration and Leaflet Mobility Considerations: Assessing Clinical Relevance

EVOLUT R TAVR Technology Review (Including EVOLUT 34mm and PRO) and Clinical Program Updates

Embolic Protection Devices For TAVR Procedures: Lessons Learned From SENTINEL and Other Experiences

SAPIEN 3 Procedural Pearls (Including Optimal Sizing Algorithms)

SAPIEN 3 TAVR Technology Review (Including Sapien 3 ULTRA) and Clinical Program Updates

Intermediate-Risk TAVR Substantially More Cost-effective Than Surgery

Industry Perspective on Real-World Evidence for TAVR Outcomes Where are the Opportunities?

TCT 40: Outcome Of Patients Undergoing Trans-Catheter Implantation of Aortic Valve With Previous Mitral Valve Prosthesis (Optimal Study)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content